These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
526 related items for PubMed ID: 20698241
1. Intraductal papillary mucinous neoplasms of the pancreas--predictors of malignancy. Fan F, Lai EC, Xie F, Yang JM, Xu F, Kan T, Shen RX, Yang XY, Lau Wan Y, Wu MC. Hepatogastroenterology; 2010; 57(99-100):635-9. PubMed ID: 20698241 [Abstract] [Full Text] [Related]
2. Invasive IPMN and MCN: same organ, different outcomes? Kargozaran H, Vu V, Ray P, Bagaria S, Steen S, Ye X, Gagandeep S. Ann Surg Oncol; 2011 Feb; 18(2):345-51. PubMed ID: 20809175 [Abstract] [Full Text] [Related]
3. Predictors of malignant intraductal papillary mucinous neoplasm of the pancreas. Mimura T, Masuda A, Matsumoto I, Shiomi H, Yoshida S, Sugimoto M, Sanuki T, Yoshida M, Fujita T, Kutsumi H, Ku Y, Azuma T. J Clin Gastroenterol; 2010 Oct; 44(9):e224-9. PubMed ID: 20453661 [Abstract] [Full Text] [Related]
4. Treatment strategy for intraductal papillary mucinous neoplasm of the pancreas based on malignant predictive factors. Hirono S, Tani M, Kawai M, Ina S, Nishioka R, Miyazawa M, Fujita Y, Uchiyama K, Yamaue H. Arch Surg; 2009 Apr; 144(4):345-9; discussion 349-50. PubMed ID: 19380648 [Abstract] [Full Text] [Related]
5. Clinical fate of branch duct and mixed forms of intraductal papillary mucinous neoplasia of the pancreas. Bournet B, Kirzin S, Carrère N, Portier G, Otal P, Selves J, Musso C, Suc B, Moreau J, Fourtanier G, Pradère B, Lazorthes F, Escourrou J, Buscail L. J Gastroenterol Hepatol; 2009 Jul; 24(7):1211-7. PubMed ID: 19476563 [Abstract] [Full Text] [Related]
7. Prognostic impact of pancreatic margin status in the intraductal papillary mucinous neoplasms of the pancreas. Fujii T, Kato K, Kodera Y, Kanda M, Nagai S, Yamada S, Kanzaki A, Sugimoto H, Nomoto S, Takeda S, Morita S, Nakamura S, Nakao A. Surgery; 2010 Aug; 148(2):285-90. PubMed ID: 20434746 [Abstract] [Full Text] [Related]
8. Invasive intraductal papillary-mucinous neoplasm of the pancreas: comparison with pancreatic ductal adenocarcinoma. Murakami Y, Uemura K, Sudo T, Hayashidani Y, Hashimoto Y, Nakashima A, Sueda T. J Surg Oncol; 2009 Jul 01; 100(1):13-8. PubMed ID: 19384908 [Abstract] [Full Text] [Related]
9. Survival and prognosis of invasive intraductal papillary mucinous neoplasms of the pancreas: comparison with pancreatic ductal adenocarcinoma. Woo SM, Ryu JK, Lee SH, Yoo JW, Park JK, Kim YT, Yoon YB. Pancreas; 2008 Jan 01; 36(1):50-5. PubMed ID: 18192881 [Abstract] [Full Text] [Related]
10. Risk factors associated with the postoperative recurrence of intraductal papillary mucinous neoplasms of the pancreas. Park J, Lee KT, Jang TH, Seo YW, Lee KH, Lee JK, Jang KT, Heo JS, Choi SH, Choi DW, Rhee JC. Pancreas; 2011 Jan 01; 40(1):46-51. PubMed ID: 21160369 [Abstract] [Full Text] [Related]
14. Nonoperative management of main pancreatic duct-involved intraductal papillary mucinous neoplasm might be indicated in select patients. Roch AM, DeWitt JM, Al-Haddad MA, Schmidt CM, Ceppa EP, House MG, Zyromski NJ, Nakeeb A, Schmidt CM. J Am Coll Surg; 2014 Jul 01; 219(1):122-9. PubMed ID: 24862887 [Abstract] [Full Text] [Related]
15. Role of intraoperative cytology combined with histology in detecting continuous and skip type intraductal cancer existence for intraductal papillary mucinous carcinoma of the pancreas. Eguchi H, Ishikawa O, Ohigashi H, Sasaki Y, Yamada T, Nakaizumi A, Uehara H, Takenaka A, Kasugai T, Imaoka S. Cancer; 2006 Dec 01; 107(11):2567-75. PubMed ID: 17054109 [Abstract] [Full Text] [Related]
16. Oncocytic-type intraductal papillary mucinous neoplasms: a unique malignant pancreatic tumor with good long-term prognosis. Marchegiani G, Mino-Kenudson M, Ferrone CR, Warshaw AL, Lillemoe KD, Fernández-del Castillo C. J Am Coll Surg; 2015 May 01; 220(5):839-44. PubMed ID: 25840549 [Abstract] [Full Text] [Related]
18. A comparison between intraductal papillary neoplasms of the biliary tract (BT-IPMNs) and intraductal papillary mucinous neoplasms of the pancreas (P-IPMNs) reveals distinct clinical manifestations and outcomes. Minagawa N, Sato N, Mori Y, Tamura T, Higure A, Yamaguchi K. Eur J Surg Oncol; 2013 Jun 01; 39(6):554-8. PubMed ID: 23506840 [Abstract] [Full Text] [Related]
19. Characteristic clinicopathological features of the types of intraductal papillary-mucinous neoplasms of the pancreas. Ishida M, Egawa S, Aoki T, Sakata N, Mikami Y, Motoi F, Abe T, Fukuyama S, Sunamura M, Unno M, Moriya T, Horii A, Furukawa T. Pancreas; 2007 Nov 01; 35(4):348-52. PubMed ID: 18090241 [Abstract] [Full Text] [Related]
20. Recurrences after surgical resection of intraductal papillary mucinous neoplasm of the pancreas: a single-center study of recurrence predictive factors. Passot G, Lebeau R, Hervieu V, Ponchon T, Pilleul F, Adham M. Pancreas; 2012 Jan 01; 41(1):137-41. PubMed ID: 22076564 [Abstract] [Full Text] [Related] Page: [Next] [New Search]